UNSPSC 51192302: Acetate/calcium/chloride/gluconate/magnesium/potassium/sodium

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class TN490. This VA Drug Class (TN490) classifies this compound as belonging to the group ELECTROLYTES/MINERALS, COMBINATIONS.

UNSPSC 51192302 Acetate/calcium/chloride/gluconate/magnesium/potassium/sodium Commodity code covers chemical supply products—specifically salts and mineral-based compounds—that state and local governments procure for water treatment, pharmaceutical, and facility operations. The work actually being solicited under this code spans municipal water pollution control operations (sodium bisulfite for chemical treatment), pharmaceutical manufacturing and wholesale distribution of generic drugs and OTC products, and related chemical-supply chains. Issuing bodies include municipal water utilities (City of Meriden, Connecticut), state cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance), and state departments of administration coordinating multi-jurisdiction pharmaceutical supply agreements. The scope reflects mixed procurement drivers: operational chemical management at local utilities and statewide aggregated pharmaceutical supply agreements serving state and local government healthcare and institutional facilities across multiple states.

Recent opportunities show geographic activity centered in the Upper Midwest and Northeast. The City of Meriden's bid for sodium bisulfite (Solicitation B027-15, due July 29, 2026) exemplifies municipal chemical procurement at the operational scale. The Minnesota Department of Administration's MMCAP RFP (S1070000015802, due March 26, 2026) represents the larger cooperative purchasing model for generic pharmaceuticals and OTC products, with multi-state participation including Oregon and performance requirements tied to three authorized wholesalers (AmerisourceBergen/Cencora, Cardinal Health 110 and 112, and Morris & Dickson). The MMCAP contract, effective July 1, 2026, carries a two-year initial term with optional extensions and requires vendors to maintain $5,000,000 commercial general liability coverage, certify cGMP and DSCSA compliance, and accept a 3 percent administrative fee against all contract purchases. Both opportunities emphasize pricing competitiveness, compliance documentation, and performance bonding.